- Home
- OGEN vs AMST Comparison
OGEN vs AMST Comparison
Compare OGEN & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- AMST
- Stock Information
- Founded
- OGEN 1996
- AMST 2017
- Country
- OGEN United States
- AMST United States
- Employees
- OGEN N/A
- AMST N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- OGEN Health Care
- AMST Technology
- Exchange
- OGEN Nasdaq
- AMST Nasdaq
- Market Cap
- OGEN 2.5M
- AMST 9.5M
- IPO Year
- OGEN N/A
- AMST 2020
- Fundamental
- Price
- OGEN $1.50
- AMST $2.77
- Analyst Decision
- OGEN
- AMST
- Analyst Count
- OGEN 0
- AMST 0
- Target Price
- OGEN N/A
- AMST N/A
- AVG Volume (30 Days)
- OGEN 1.1M
- AMST 37.4K
- Earning Date
- OGEN 08-08-2025
- AMST 05-15-2025
- Dividend Yield
- OGEN N/A
- AMST N/A
- EPS Growth
- OGEN N/A
- AMST N/A
- EPS
- OGEN N/A
- AMST N/A
- Revenue
- OGEN N/A
- AMST $82,544.00
- Revenue This Year
- OGEN N/A
- AMST N/A
- Revenue Next Year
- OGEN N/A
- AMST N/A
- P/E Ratio
- OGEN N/A
- AMST N/A
- Revenue Growth
- OGEN N/A
- AMST N/A
- 52 Week Low
- OGEN $1.35
- AMST $2.00
- 52 Week High
- OGEN $75.60
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- OGEN 27.35
- AMST 51.42
- Support Level
- OGEN $1.35
- AMST $2.51
- Resistance Level
- OGEN $4.19
- AMST $2.82
- Average True Range (ATR)
- OGEN 0.43
- AMST 0.15
- MACD
- OGEN -0.22
- AMST -0.01
- Stochastic Oscillator
- OGEN 5.14
- AMST 46.64
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.